Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Salpeter S, Greyber E, Pasternak G, Salpeter E.

Cochrane Database Syst Rev. 2002;(2):CD002967. Review. Update in: Cochrane Database Syst Rev. 2003;(2):CD002967.

PMID:
12076461
2.

Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines.

Emslie-Smith AM, Boyle DI, Evans JM, Sullivan F, Morris AD; DARTS/MEMO Collaboration.

Diabet Med. 2001 Jun;18(6):483-8.

PMID:
11472468
3.
4.

Lactic acidosis rates in type 2 diabetes.

Brown JB, Pedula K, Barzilay J, Herson MK, Latare P.

Diabetes Care. 1998 Oct;21(10):1659-63. Erratum in: Diabetes Care 1998 Dec;21(12):2203.

PMID:
9773726
5.
6.

Lactic acidosis in patients with diabetes treated with metformin.

Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA.

N Engl J Med. 1998 Jan 22;338(4):265-6. No abstract available.

8.

Contraindications to metformin therapy in patients with NIDDM.

Sulkin TV, Bosman D, Krentz AJ.

Diabetes Care. 1997 Jun;20(6):925-8.

PMID:
9167101
9.

Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

Cusi K, Consoli A, DeFronzo RA.

J Clin Endocrinol Metab. 1996 Nov;81(11):4059-67.

PMID:
8923861
10.

Clinical pharmacokinetics of metformin.

Scheen AJ.

Clin Pharmacokinet. 1996 May;30(5):359-71. Review.

PMID:
8743335
11.

Metformin-associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis.

Lalau JD, Lacroix C, De Cagny B, Fournier A.

Nephrol Dial Transplant. 1994;9 Suppl 4:126-9.

PMID:
7800245

Supplemental Content

Support Center